{"id":50195,"date":"2022-10-27T23:02:41","date_gmt":"2022-10-27T21:02:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/"},"modified":"2022-10-27T23:02:41","modified_gmt":"2022-10-27T21:02:41","slug":"cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/","title":{"rendered":"Cresco Labs to Report Third Quarter 2022 Financial Results on November 15, 2022"},"content":{"rendered":"
\n

CHICAGO–(BUSINESS WIRE)–Cresco Labs<\/b><\/a> (CSE:CL) (OTCQX:CRLBF) (\u201cCresco Labs\u201d or \u201cthe Company\u201d), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced that it will report financial results for the third quarter ended September 30th<\/sup>, 2022 on Tuesday, November 15th<\/sup>, 2022 before the market opens.\n<\/p>\n

<\/a><\/p>\n

\nThe Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.\n<\/p>\n\n\n\n\n\n\n\n
\n

\nEvent<\/b>: Cresco Labs Third Quarter 2022 Earnings Conference Call\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDate<\/b>: Tuesday, November 15th<\/sup>, 2022\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTime<\/b>: 8:30 am EST\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nWebcast<\/b>: Link<\/a>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDial-in<\/b>: 1-844-200-6205 (US Toll Free), 1-833-950-0062 (CDN Toll Free), 1-646-904-5544 (US Local), +1 929-526-1599 (Other)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAccess Code<\/b>: 334786\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nArchived access to the webcast will be available for one year on the Cresco Labs investor relations website.<\/a>\n<\/p>\n

\nAbout Cresco Labs Inc.<\/b>\n<\/p>\n

\nCresco Labs is one of the largest vertically integrated multi state cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (\u201cCPG\u201d) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy’s Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs\u2019 national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry\u2019s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/i>
Jason Erkes, Cresco Labs
\n
Chief Communications Officer
\n
press@crescolabs.com<\/a>\n<\/p>\n

\nInvestors:<\/i>
Megan Kulick, Cresco Labs
\n
Senior Vice President, Investor Relations
\n
investors@crescolabs.com<\/a>\n<\/p>\n

\nFor general Cresco Labs inquiries:<\/i>
312-929-0993
\n
info@crescolabs.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (\u201cCresco Labs\u201d or \u201cthe Company\u201d), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced that it will report financial results for the third quarter ended September 30th, 2022 on Tuesday, November 15th, 2022 before the market opens. The Company will host a … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50195","6":"format-standard","7":"category-industry"},"yoast_head":"\nCresco Labs to Report Third Quarter 2022 Financial Results on November 15, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cresco Labs to Report Third Quarter 2022 Financial Results on November 15, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (\u201cCresco Labs\u201d or \u201cthe Company\u201d), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced that it will report financial results for the third quarter ended September 30th, 2022 on Tuesday, November 15th, 2022 before the market opens. The Company will host a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-27T21:02:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221027006025\/en\/1055904\/21\/PR_BW_LOGO.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cresco Labs to Report Third Quarter 2022 Financial Results on November 15, 2022\",\"datePublished\":\"2022-10-27T21:02:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\\\/\"},\"wordCount\":359,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221027006025\\\/en\\\/1055904\\\/21\\\/PR_BW_LOGO.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\\\/\",\"name\":\"Cresco Labs to Report Third Quarter 2022 Financial Results on November 15, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221027006025\\\/en\\\/1055904\\\/21\\\/PR_BW_LOGO.jpg\",\"datePublished\":\"2022-10-27T21:02:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221027006025\\\/en\\\/1055904\\\/21\\\/PR_BW_LOGO.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221027006025\\\/en\\\/1055904\\\/21\\\/PR_BW_LOGO.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cresco Labs to Report Third Quarter 2022 Financial Results on November 15, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cresco Labs to Report Third Quarter 2022 Financial Results on November 15, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/","og_locale":"en_US","og_type":"article","og_title":"Cresco Labs to Report Third Quarter 2022 Financial Results on November 15, 2022 - Pharma Trend","og_description":"CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (\u201cCresco Labs\u201d or \u201cthe Company\u201d), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced that it will report financial results for the third quarter ended September 30th, 2022 on Tuesday, November 15th, 2022 before the market opens. The Company will host a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-27T21:02:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221027006025\/en\/1055904\/21\/PR_BW_LOGO.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cresco Labs to Report Third Quarter 2022 Financial Results on November 15, 2022","datePublished":"2022-10-27T21:02:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/"},"wordCount":359,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221027006025\/en\/1055904\/21\/PR_BW_LOGO.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/","url":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/","name":"Cresco Labs to Report Third Quarter 2022 Financial Results on November 15, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221027006025\/en\/1055904\/21\/PR_BW_LOGO.jpg","datePublished":"2022-10-27T21:02:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221027006025\/en\/1055904\/21\/PR_BW_LOGO.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221027006025\/en\/1055904\/21\/PR_BW_LOGO.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-to-report-third-quarter-2022-financial-results-on-november-15-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cresco Labs to Report Third Quarter 2022 Financial Results on November 15, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50195"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50195\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}